Cost-effectiveness of monolayers and human papillomavirus testing compared to that of conventional Papanicolaou smears for cervical cancer screening: Protocol of the study of the French Society of Clinical Cytology

2001 ◽  
Vol 24 (6) ◽  
pp. 412-420 ◽  
Author(s):  
Béatrix Cochand-Priollet ◽  
Catherine Le Galès ◽  
Patricia de Cremoux ◽  
Vincent Molinié ◽  
Xavier Sastre-Garau ◽  
...  
2010 ◽  
Vol 101 (3) ◽  
pp. 220-225 ◽  
Author(s):  
Arthi Vijayaraghavan ◽  
Molly B. Efrusy ◽  
Marie-Hélène Mayrand ◽  
Christopher C. Santas ◽  
Patricia Goggin

2003 ◽  
Vol 127 (8) ◽  
pp. 984-990
Author(s):  
David R. Bolick

Abstract Human papillomavirus testing is becoming an integral component of cervical cancer screening. Market forces will require most laboratories that perform Papanicolaou tests to develop a system for handling human papillomavirus testing also. Data and information are presented that may facilitate laboratories when addressing the following issues in the process of developing a human papillomavirus testing service: Which methodology is the best fit for the laboratory? Is it better to develop an in-house testing service or to send it out? How do I get started? What are the financial and economic issues, and how should they be managed?


Sign in / Sign up

Export Citation Format

Share Document